# Survival outcomes in patients with chemotherapy-naive metastatic castration-resistant prostate cancer treated with enzalutamide or abiraterone acetate

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/survival-outcomes-in-patients-with-chemotherapy-naive-metastatic-castration/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Scott T. Tagawa,Krishnan Ramaswamy,Ahong Huang,Jack Mardekian,Neil M. Schultz,Li Wang,Rickard Sandin,Stanislav Lechpammer,Daniel J. George |
| Citations | 61 |
| DOI | 10.1038/s41391-021-00318-3 |
| Fields | Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://www.nature.com/articles/s41391-021-00318-3.pdf |
| OpenAlex ID | https://openalex.org/W3131822249 |
| PMID | 33612825 |
| Type | article |
| Year | 2021 |

## Paper authors

- [Li Wang](https://scholariq.org/researchers/li-wang-2/)

## Paper primary topic

- [Prostate Cancer Treatment and Research](https://scholariq.org/topics/prostate-cancer-treatment-and-research/)

## Paper topics

- [Prostate Cancer Treatment and Research](https://scholariq.org/topics/prostate-cancer-treatment-and-research/)
- [Radiopharmaceutical Chemistry and Applications](https://scholariq.org/topics/radiopharmaceutical-chemistry-and-applications/)
- [Bone health and treatments](https://scholariq.org/topics/bone-health-and-treatments/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.